山柰酚抗酒精性肝损伤及其机制研究.docx

山柰酚抗酒精性肝损伤及其机制研究 摘要：酒精性肝病是由于长期大量饮酒引起的肝脏损伤，目前尚无有效的治疗方法。山柰酚是一种天然的生物活性物质，具有抗氧化、抗炎、抗癌等多种生物学活性。本文通过动物实验研究山柰酚对酒精性肝病的保护作用及其机制。 实验结果表明，山柰酚可显著降低酒精性肝病大鼠血清ALT、AST及肝脏组织MDA、SOD、CAT水平的异常升高和下降，预防并逆转脂质过氧化和氧化应激。同时，山柰酚还能减轻酒精性肝病对肝脏组织形态和结构的损害，降低肝脏组织炎症反应指标的表达。 山柰酚的保护作用可能是通过抑制NF-κB和iNOS的表达而实现的，从而减轻酒精性肝病所引起的炎症反应。此外，山柰酚还能显著降低MMP-2、MMP-9及其上游调控因子的表达，从而抑制肝脏组织的基质降解和纤维化反应。 本研究结果表明，山柰酚具有良好的抗酒精性肝病作用，可以作为一种潜在的治疗酒精性肝病的药物。 关键词：山柰酚；酒精性肝病；抗氧化；抗炎；抗纤维化 Abstract: Alcoholic liver disease is a liver injury caused by long-term heavy alcohol consumption, and there is currently no effective treatment. Mangiferin is a natural bioactive substance with various biological activities such as antioxidant, anti-inflammatory, and anticancer. This study investigated the protective effect of mangiferin on alcoholic liver disease and its mechanism through animal experiments. The results showed that mangiferin significantly reduced the abnormal increase in serum ALT, AST, liver tissue MDA, SOD, and CAT levels in alcoholic liver disease rats and prevented and reversed lipid peroxidation and oxidative stress. At the same time, mangiferin also alleviated the damage to liver tissue morphology and structure caused by alcoholic liver disease and reduced the expression of liver tissue inflammatory reaction markers. The protective effect of mangiferin may be achieved by inhibiting the expression of NF-κB and iNOS, thereby reducing the inflammatory response caused by alcoholic liver disease. In addition, mangiferin significantly reduced the expression of MMP-2, MMP-9, and their upstream regulating factors, thereby inhibiting the matrix degradation and fibrosis reaction of the liver tissue. The results of this study indicate that mangiferin has a good anti-alcoholic liver disease effect and can be used as a potential drug for the treatment of alcoholic liver disease. Keywords: mangiferin; alcoholic liver disease; antioxidant; anti-inflammatory; anti-fibrosis